These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29054805)

  • 41. [Cancer treatment in elderly patients: evidence and clinical research].
    Repetto L; Luciani A
    Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal cancer in the elderly: is palliative chemotherapy of value?
    Honecker F; Köhne CH; Bokemeyer C
    Drugs Aging; 2003; 20(1):1-11. PubMed ID: 12513112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of a frailty index in older cancer patients with solid tumours.
    McCarthy AL; Peel NM; Gillespie KM; Berry R; Walpole E; Yates P; Hubbard RE
    BMC Cancer; 2018 Sep; 18(1):892. PubMed ID: 30217171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Laurent M; Des Guetz G; Bastuji-Garin S; Culine S; Caillet P; Aparicio T; Audureau E; Carvahlo-Verlinde M; Reinald N; Tournigand C; Landre T; LeThuaut A; Paillaud E; Canouï-Poitrine F
    Am J Clin Oncol; 2018 Jan; 41(1):73-80. PubMed ID: 26669742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk of adverse outcomes in hospitalized older patients in relation to a frailty index based on a comprehensive geriatric assessment.
    Evans SJ; Sayers M; Mitnitski A; Rockwood K
    Age Ageing; 2014 Jan; 43(1):127-32. PubMed ID: 24171946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
    Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
    Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting.
    Chiusole B; Tortorelli I; Galiano A; Murtas F; Ahcene-Djaballah S; Tierno G; Bergo E; Banzato A; Gatti M; Di Maggio A; Sergi G; Rastrelli M; Sbaraglia M; Zagonel V; Brunello A
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831386
    [No Abstract]   [Full Text] [Related]  

  • 48. A Comparison of Two Preoperative Frailty Models in Predicting Postoperative Outcomes in Geriatric General Surgical Patients.
    Andreou A; Lasithiotakis K; Venianaki M; Xenaki S; Chlouverakis G; Petrakis I; Chalkiadakis G
    World J Surg; 2018 Dec; 42(12):3897-3902. PubMed ID: 30014293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.
    Aaldriks AA; Maartense E; le Cessie S; Giltay EJ; Verlaan HA; van der Geest LG; Kloosterman-Boele WM; Peters-Dijkshoorn MT; Blansjaar BA; van Schaick HW; Nortier JW
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):205-12. PubMed ID: 20709565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elderly patients with colorectal cancer: treatment modalities and survival in France. National data from the ThInDiT cohort study.
    Doat S; Thiébaut A; Samson S; Ricordeau P; Guillemot D; Mitry E
    Eur J Cancer; 2014 May; 50(7):1276-83. PubMed ID: 24447833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timing of adjuvant chemotherapy in colorectal cancer.
    Dos Santos LV; Faria TM; Lima AB; Abdalla KC; de Moraes ED; Cruz MR; Lima JP
    Colorectal Dis; 2016 Sep; 18(9):871-6. PubMed ID: 26900665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
    Tucci A; Martelli M; Rigacci L; Riccomagno P; Cabras MG; Salvi F; Stelitano C; Fabbri A; Storti S; Fogazzi S; Mancuso S; Brugiatelli M; Fama A; Paesano P; Puccini B; Bottelli C; Dalceggio D; Bertagna F; Rossi G; Spina M;
    Leuk Lymphoma; 2015 Apr; 56(4):921-6. PubMed ID: 25110825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do geriatric outpatients adhere to medication changes advised after assessment? An exploratory pilot study.
    Tulner LR; Frankfort SV; Wesselius F; van Campen JP; Koks CH; Beijnen JH
    Curr Clin Pharmacol; 2009 May; 4(2):154-8. PubMed ID: 19442081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive geriatric assessment predicts mortality and adverse outcomes in hospitalized older adults.
    Avelino-Silva TJ; Farfel JM; Curiati JA; Amaral JR; Campora F; Jacob-Filho W
    BMC Geriatr; 2014 Dec; 14():129. PubMed ID: 25464932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer.
    Procaccio L; Bergamo F; Gatti M; Chiusole B; Tierno G; Bergo E; Daniel F; Nappo F; Maddalena G; Rasola C; Barsotti G; De Grandis MC; Piva VM; Rizzato MD; Sergi G; Brunello A; Zagonel V; Lonardi S
    Eur J Cancer; 2022 Dec; 177():112-119. PubMed ID: 36335781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.
    Caillet P; Laurent M; Bastuji-Garin S; Liuu E; Culine S; Lagrange JL; Canoui-Poitrine F; Paillaud E
    Clin Interv Aging; 2014; 9():1645-60. PubMed ID: 25302022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
    Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
    J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
    Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.